Iran’s pharmaceutical market was worth 160 trillion rials ($4 billion) in the last fiscal year that ended in March, of which domestically-made drugs products accounted for 71% of the total and the rest was imported, head of the Food and Drug Association, Rasoul Dinarvand said.
Speaking at the inauguration ceremony of Iran Pharma Expo on Tuesday, Dinarvand said domestic pharmaceutical products are expected to account for more than 75% share of the market by the end of the Sixth Five-Year Economic Development Plan (2017-22), IRNA reported.
He reiterated the need for expanding exports. “Pharmaceutical imports now stand at $1.1 billion while exports are merely $200 million. Our goal is to achieve a trade surplus by 2025.”
Iran Pharma Expo, an international trade fair for pharmaceutical products, machinery and services, opened in Tehran on Tuesday at Tehran’s Grand Mosalla and will end today.
Add new comment
Read our comment policy before posting your viewpoints